Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for invivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers

Biomaterials

Volumn 44, Issue , 2015, Pages 82-90

  Zhang, Ling'e ^a,b   Zeng, Leyong ^a,c   Pan, Yuanwei ^a   Luo, Song ^c   Ren, Wenzhi ^a   Gong, An ^a   Ma, Xuehua ^a   Liang, Hongze ^b   Lu, Guangming ^c,d   Wu, Aiguo ^a  

^a NINGBO INSTITUTE OF MATERIALS TECHNOLOGY AND ENGINEERING   (China)

^b NINGBO UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

Gd based upconversion luminescence; Magnetic resonance imaging; Near infrared responsive photodynamic therapy; TiO2 inorganic photosensitizer

Indexed keywords

BIOCOMPATIBILITY; DISEASES; HISTOLOGY; INFRARED DEVICES; LANTHANUM COMPOUNDS; LIGHT; LUMINESCENCE; MAGNETISM; MAMMALS; NANOCOMPOSITES; OXIDE MINERALS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; RESONANCE; SILICA; SILICON; SIO2 NANOPARTICLES; SODIUM ALLOYS; THULIUM ALLOYS; TIO2 NANOPARTICLES; TITANIUM DIOXIDE; TUMORS; YTTERBIUM ALLOYS;

DEEP PENETRATION; INHIBITION RATIO; LIGHT STABILITY; MRI CONTRAST AGENTS; NEAR INFRARED; PHOTODYNAMIC THERAPY (PDT); ULTRAVIOLET LIGHTS; UP-CONVERSION LUMINESCENCE;

MAGNETIC RESONANCE IMAGING;

FOLIC ACID; GADOLINIUM; NANOCOMPOSITE; SILICON DIOXIDE; TETRAETHOXYSILANE; THULIUM; THULIUM OXIDE; TITANIUM BUTOXIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; YTTERBIUM; YTTERBIUM OXIDE; PHOTOSENSITIZING AGENT; TIO2-SIO2; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; UTERINE CERVIX CARCINOMA; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; LUMINESCENCE; MCF 7 CELL LINE; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; RADIATION SCATTERING; STATIC ELECTRICITY; ULTRASTRUCTURE; X RAY DIFFRACTION;

MUS MUSCULUS;

ANIMALS; CELL DEATH; CELL SURVIVAL; FEMALE; FOLIC ACID; GADOLINIUM; HELA CELLS; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MCF-7 CELLS; MICE; MICE, NUDE; NANOCOMPOSITES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCATTERING, RADIATION; SILICON DIOXIDE; SPECTROSCOPY, NEAR-INFRARED; STATIC ELECTRICITY; TITANIUM; X-RAY DIFFRACTION;

EID: 84921305902     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.12.040     Document Type: Article

References (36)

1. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995, 24:19-33.
2. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
3. Gu H., Xu K., Yang Z., Chang C.K., Xu B. Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. Chem Commun 2005, 4270-4272.
4. Cheng Y., Samia A.C., Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for invivo photodynamic therapy of cancer. JAm Chem Soc 2008, 130:10643-10647.
5. Moan J. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. Cancer Lett 1986, 33:45-53.
6. Stummer W., Pichlmeier U., Meinel T., Wiestler O.D., Zanella F., Reulen H.J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006, 7:392-401.
7. Zhao T., Wu H., Yao S.Q., Xu Q.-H., Xu G.Q. Nanocomposites containing gold nanorods and porphyrin-doped mesoporous silica with dual capability of two-photon imaging and photosensitization. Langmuir 2010, 26:14937-14942.
8. Xia L., Kong X., Liu X., Tu L., Zhang Y., Chang Y., et al. An upconversion nanoparticle - zinc phthalocyanine based nanophotosensitizer for photodynamic therapy. Biomaterials 2014, 35:4146-4156.
9. Park Y.I., Kim H.M., Kim J.H., Moon K.C., Yoo B., Lee K.T., et al. Theranostic probe based on lanthanide-doped nanoparticles for simultaneous invivo dual-modal imaging and photodynamic therapy. Adv Mater 2012, 24:5755-5761.
10. Jin S., Zhou L., Gu Z., Tian G., Yan L., Ren W., et al. Anew near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Nanoscale 2013, 5:11910-11918.
11. Qiao X.F., Zhou J.C., Xiao J.W., Wang Y.F., Sun L.D., Yan C.H. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy invitro. Nanoscale 2012, 4:4611-4623.
12. Zhao Z., Han Y., Lin C., Hu D., Wang F., Chen X., et al. Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. Chem Asian J 2012, 7:830-837.
13. Allison R.R., Downie G.H., Cuenca R., Hu X.H., Childs C.J.H., Sibata C.H. Photosensitizers in clinical PDT. Photodiagn Photodyn 2004, 1:27-42.
14. Qian H.S., Guo H.C., Ho P.C., Mahendran R., Zhang Y. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small 2009, 5:2285-2290.
15. 2 surfaces: principles, mechanisms, and selected results. Chem Rev 1995, 95:735-758.
16. 2 photocatalysis under weak UV illumination. JPhys Chem B 1998, 102:2699-2704.
17. 2. ACS Appl Mater Interf 2013, 6:340-348.
18. 2 core@shell microcrystals. Appl Catal B-Environ 2013, 142-143:377-386.
19. 2 shells under mild conditions and their upconversion-based photocatalysis. Nanoscale 2013, 5:8930-8933.
20. 2-oligonucleotide nanocomposites. Nat Mater 2003, 2:343-346.
21. Rozhkova E.A., Ulasov I., Lai B., Dimitrijevic N.M., Lesniak M.S., Rajh T. Ahigh-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett 2009, 9:3337-3342.
22. 2 nanoparticles for photocatalytic cancer-cell treatment. Small 2007, 3:850-853.
23. 2-polyethylene glycol compound: evaluation of antitumor effect on glioma cells and spheroids invitro. Photochem Photobiol 2010, 86:964-971.
24. Higuchi Y. Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 2003, 66:1527-1535.
25. 2 nanocomposites for magnetic resonance imaging and potential photodynamic therapy. Nanoscale 2013, 5:2107-2113.
26. Liu K., Wang Y., Kong X., Liu X., Zhang Y., Tu L., et al. Multispectral upconversion luminescence intensity ratios for ascertaining the tissue imaging depth. Nanoscale 2014, 6:9257-9263.
27. Xu C.T., Svensson N., Axelsson J., Svenmarker P., Somesfalean G., Chen G., et al. Autofluorescence insensitive imaging using upconverting nanocrystals in scattering media. Appl Phys Lett 2008, 93. 171103-171103-3.
28. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for invivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
29. Wang F., Han Y., Lim C.S., Lu Y., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
30. Wang F., Wang J., Liu X. Direct evidence of a surface quenching effect on size-dependent luminescence of upconversion nanoparticles. Angew Chem Int Ed 2010, 122:7618-7622.
31. 3+-ion-doped upconversion nanoprobes: relaxivity mechanism probing and sensitivity optimization. Adv Funct Mater 2013, 23:298-307.
32. 4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts invivo. ACS Nano 2012, 7:330-338.
33. 1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
34. 4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging. Biomaterials 2013, 34:5218-5225.
35. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
36. 2 core/shell nanoparticles with controllable shell thickness. JNanosci Nanotechno 2011, 11:9761-9764.